Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on Sep 27, 2022 12:48pm
74 Views
Post# 34989746

RE:RE:RE:RE:57,000 views, THTX YouTube video link below

RE:RE:RE:RE:57,000 views, THTX YouTube video link belowI don't say this retail market is not a good thing to have. The question is how to get it without telling falsehoods like the guy in the video? Thera's management cannot be associated with spreading around such misleading stuff.

SPCEO1 wrote: Once the retail crowd is engaged, they can stick around for a while as they are operating in an alternative universe that makes no sense to us. Did you know that GME  is the best performing stock since the covid pandemic started and by a large margin over the next best performing stock since 2/20?It is cartoonish stuff, but it can persist for longer than we might imagine. In this case, these are traders in it for the approval. The approval will likely come and the stock might jump more than we know is justified as these folks in their alternative universe chase it higher. 

jfm1330 wrote: If the falsehoods in this video are the reason for the rise, we are in Cytodyn territory. So good for those who wants to get out asap, but it will fall as soon as they will see that Trogarzo IV push approval has no impact on the SP.


jfm1330 wrote: I still have a hard time believing this guy and his falsehoods are the reason for the little run up. It is clear that he knows nothing about Thera and Trogarzo.


TH1902 wrote: Was curious so I found the video that referenced THTX, here it is, starts around 4:30 point, pitched as a trade on FDA response expected Oct. 3rd

https://www.youtube.com/watch?v=O6tkOY0GTVI

 

 

 




<< Previous
Bullboard Posts
Next >>